Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Outpatient Claims Data Could Be Released By June 1, AdvaMed Says

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed remains hopeful that the Centers for Medicare & Medicaid Services will release the fiscal 2001 outpatient prospective payment system (OPPS) claims data by June 1, roughly one month prior to publication of the FY 2003 proposed rule

You may also be interested in...



OPPS Data Release Reverses Scully’s Earlier Stance; AdvaMed “Appreciative”

CMS will release its outpatient prospective payment system 2001 claims data to the public, a decision that represents a victory for industry stakeholders eager to examine the methodology that will be used to calculate the 2003 OPPS update

Concurrent CMS/FDA Review Is “The Real Issue,” Not OPPS Data – Scully

AdvaMed is hoping to assist the Centers for Medicare & Medicaid Services as the agency devises its 2003 outpatient prospective payment system (OPPS) update, but will be forced to do so without the benefit of analyzing data from years past

EWG Study Suggests More Than One In 10 Talc-Based Cosmetics Contain Asbestos

The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.

UsernamePublicRestriction

Register

OM002075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel